All blog posts
Showing 36 out of 93 results
04 September 2024
CJEU finds EC's recent policy of referrals for deals below the merger thresholds illegal - more certainty for companies doing deals?
15 August 2024
H1 2024 – a steady start for biopharma M&A
07 August 2024
A new Labour Government – what might this mean for the UK life sciences industry?
01 August 2024
The EU AI Act Is In Force From Today (1 August 2024)
29 July 2024
Commission investigation into anticompetitive disparagement ends with commitments
23 July 2024
UPC finds Edwards' patent valid (as amended) – Meril's revocations dismissed
16 July 2024
UPC revokes Amgen's patent in the first case filed at the UPC
12 July 2024
The EU focuses its Industrial Policy on Critical Industries - STEP Regulation solidifies Biotechnology focus
11 July 2024
EU FRAND regulation – what next for FRAND litigation in Europe?
02 July 2024
AI In Life Sciences – What Changes To The Regulatory And Innovation Landscape Could The UK Elections Bring?
02 July 2024
Recent additions to Life Sciences Notes
28 June 2024
Biotech in the crosshairs of global politics - the draft US Biosecure Act
Showing 36 out of 93 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Life Sciences Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Life Sciences Sector, London